icr.ac.uk1d
Help us to transform the future for people with hard-to-treat cancers
Pancreatic cancer is notorious for being highly aggressive and difficult to treat. Survival rates for this disease have barely improved at all in the last four decades, with only five per cent of ...
icr.ac.uk7d
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including ...
icr.ac.uk1d
New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, ...
icr.ac.uk1d
Researchers identify what drives PARP inhibitor resistance in advanced breast cancer
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This ...
icr.ac.uk13d
ICR researcher wins prestigious clinical science award
John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, and Honorary Consultant in Medical Oncology ...
icr.ac.uk1d
Data Science at the ICR
From mapping the paths of cancer evolution, to the design and discovery of novel drugs - we are leading in innovative cancer informatics. Cancer is a complex, ever-changing set of diseases, and new ...
icr.ac.uk13d
The Clinical Trials and Statistics Unit at the ICR (ICR-CTSU)
The ICR-CTSU is a CR-UK funded, internationally recognised methodologist led clinical trials unit, providing cancer-focussed clinical trial research expertise. We lead pioneering, efficient, ...
icr.ac.uk8d
New screening trial to save thousands of men’s lives from prostate cancer
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen ...
icr.ac.uk22d
London Cancer Hub partners lace up to raise money for the ICR
Employees from land developer Socius have donned their running shoes to raise money for The Institute of Cancer Research – as members of our 2024 London Marathon team. Socius’ Head of Engagement Liam ...
icr.ac.uk21d
From cancer diagnosis to London Marathon mission – Harry’s story
As a fit and healthy former firefighter, Harry Hall didn’t think there was anything to worry about when he developed a lump in his neck. But after his wife persuaded him to go to the doctors, tests ...
icr.ac.uk15d
Science Talk
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...
icr.ac.uk15d
Science Talk
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...